###begin article-title 0
Genetic loci contributing to hemophagocytic lymphohistiocytosis do not confer susceptibility to systemic-onset juvenile idiopathic arthritis
###end article-title 0
###begin p 1
Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.
###end p 1
###begin title 2
Objective
###end title 2
###begin p 3
###xml 79 97 79 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRF1, GZMB, UNC13D</italic>
###xml 103 109 103 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rab27a</italic>
To investigate whether single-nucleotide polymorphisms (SNPs) within the genes PRF1, GZMB, UNC13D, and Rab27a, which are involved in natural killer cell dysfunction and known to contribute to the risk of hemophagocytic lymphohistiocytosis (HLH), confer an increased risk of susceptibility to systemic-onset juvenile idiopathic arthritis (JIA).
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 21 25 21 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRF1</italic>
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GZMB</italic>
###xml 56 62 56 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UNC13D</italic>
###xml 75 81 75 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rab27a</italic>
###xml 147 155 <span type="species:ncbi:9606">patients</span>
Four SNPs across the PRF1 gene locus, 5 for GZMB, 7 for UNC13D, and 11 for Rab27a were investigated using MassArray genotyping in 133 UK Caucasian patients with systemic-onset JIA and 384 ethnically matched unrelated control subjects. Additional control genotypes were accessed from the data generated by the Wellcome Trust Case Control Consortium.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
No significant association was found between any SNP within the 4 selected loci and systemic-onset JIA, by either single-point or haplotype analysis.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
The results of this study demonstrate that genes involved in HLH do not confer a significant risk of association with systemic-onset JIA.
###end p 9
###begin p 10
###xml 91 92 91 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 170 171 170 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">2</xref>
###xml 682 683 682 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 684 685 684 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 160 168 <span type="species:ncbi:9606">patients</span>
Systemic-onset juvenile idiopathic arthritis (JIA) constitutes 10-20% of all cases of JIA (1) but accounts for two-thirds of the mortality that occurs in these patients (2). The major cause of mortality over the last decade has been macrophage activation syndrome (MAS) or hemophagocytic lymphohistiocytosis (HLH). MAS is a severe, potentially life-threatening condition characterized by the excessive activation of well-differentiated macrophages. It results in fever, hepatosplenomegaly, lymphadenopathy, severe cytopenia, serious liver disease, coagulopathy, and neurologic involvement. MAS is usually seen with systemic-onset JIA and very rarely with the other subtypes of JIA (3,4).
###end p 10
###begin p 11
###xml 172 173 172 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 415 416 415 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 671 672 671 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 673 674 673 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 675 676 675 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 784 785 784 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 786 787 786 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 138 146 <span type="species:ncbi:9606">patients</span>
###xml 342 350 <span type="species:ncbi:9606">children</span>
###xml 945 953 <span type="species:ncbi:9606">patients</span>
A variety of triggers, including viral infections, active systemic disease, and drugs, have been implicated in the pathogenesis of MAS in patients with systemic-onset JIA (3). The true incidence of MAS in this subtype of JIA is not known. In one retrospective review of cases from a tertiary institution, MAS developed in 7 (6.8%) of the 103 children in whom systemic-onset JIA was diagnosed over a 20-year period (5). Those investigators, however, postulated that the true incidence of MAS might have been much higher, since mild cases of MAS are not always diagnosed. It is widely acknowledged by many pediatric rheumatologists that subclinical MAS is seen frequently (3,6,7). It has been speculated that MAS and systemic-onset JIA are simply "different ends of the same spectrum" (3,7). The presence of coagulation abnormalities and greatly elevated serum ferritin levels, both of which are characteristic features of MAS, in the majority of patients with active systemic-onset JIA is consistent with this idea.
###end p 11
###begin p 12
###xml 241 242 241 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 772 776 772 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRF1</italic>
###xml 788 793 788 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UNC13</italic>
###xml 795 817 795 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Caenorhabditis elegans</italic>
###xml 832 838 832 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UNC13D</italic>
###xml 851 852 851 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 1066 1070 1066 1070 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GZMB</italic>
###xml 1149 1153 1149 1153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GZMB</italic>
###xml 1268 1274 1268 1274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rab27a</italic>
###xml 1384 1385 1384 1385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 664 672 <span type="species:ncbi:9606">patients</span>
###xml 795 817 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
###xml 1350 1358 <span type="species:ncbi:9606">patients</span>
It is increasingly recognized that MAS bears a close resemblance to a histiocytic disorder, secondary HLH, that is seen in a heterogeneous group of diseases, including infections, neoplasms, hematologic conditions, and autoimmune disorders (8). The current classification of histiocytic disorders categorizes hemophagocytic syndromes as either primary or secondary. Primary HLH includes a clearly familial form and a sporadic form without a clear family history that is nonetheless thought to be genetic in origin. Secondary HLH is seen in the context of a wide variety of conditions. Our 4 candidate genes were selected for investigation because, in up to 50% of patients with primary HLH, the underlying defect is caused by mutations in the genes encoding for perforin (PRF1; 10q22) or UNC13 (Caenorhabditis elegans homolog of D [UNC13D]; 17q25.1) (9). Perforin is required to deliver granzyme B to target cells, after which an apoptotic program is initiated, leading to the demise of the target cells. Thus far, mutations within the gene encoding for granzyme B (GZMB; 14q11.2) have not been described in cases of HLH, but the functional role of GZMB suggests it is a valid candidate for genetic investigation. Finally, mutations in Ras-associated protein Rab 27A (Rab27a; 15q21) have been shown to play a causal role in the development of HLH in patients with Griscelli syndrome (9).
###end p 12
###begin p 13
###xml 102 104 102 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">10</xref>
###xml 407 409 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">11</xref>
###xml 746 764 746 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRF1, GZMB, UNC13D</italic>
###xml 769 775 769 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rab27a</italic>
###xml 83 91 <span type="species:ncbi:9606">patients</span>
###xml 121 129 <span type="species:ncbi:9606">patients</span>
###xml 331 339 <span type="species:ncbi:9606">patients</span>
###xml 452 460 <span type="species:ncbi:9606">patients</span>
###xml 670 678 <span type="species:ncbi:9606">patients</span>
In a study by Grom et al, natural killer (NK) cell activity was shown to be low in patients with MAS (10). Some of these patients also had low levels of perforin expression, although genetic analysis did not identify the mutations that had been subjected to screening. Recently, NK cell dysfunction was investigated in a cohort of patients with pauciarticular JIA, polyarticular JIA, or systemic-onset JIA (11). The results of the study showed that in patients with systemic-onset JIA who had not yet had an episode of MAS, there was a decrease in NK cell function, similar to that seen in HLH. In the present study we therefore hypothesized that defective apoptosis in patients with systemic-onset JIA could be due to polymorphisms in the genes PRF1, GZMB, UNC13D, or Rab27a.
###end p 13
###begin title 14
PATIENTS AND METHODS
###end title 14
###begin title 15
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients and controls
###end title 15
###begin p 16
###xml 568 570 568 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 255 260 <span type="species:ncbi:9606">human</span>
###xml 315 323 <span type="species:ncbi:9606">patients</span>
Blood samples were obtained from all subjects following the provision of informed consent. Ethics approval was obtained from the Multi-centre Research Ethics Committee (MREC 99/8/84) and the University of Manchester committee on the ethics of research on human beings (8/92/[i][b]). DNA samples were collected from patients with JIA as part of the British Society for Paediatric and Adolescent Rheumatology national repository for JIA. The diagnosis of JIA was classified according to the International League of Associations for Rheumatology classification criteria (12).
###end p 16
###begin p 17
###xml 553 555 541 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
###xml 718 719 706 707 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 34 42 <span type="species:ncbi:9606">patients</span>
###xml 301 308 <span type="species:ncbi:9606">patient</span>
DNA samples from 133 UK Caucasian patients with systemic-onset JIA were available for genotyping. A population of unrelated and ethnically matched healthy individuals (n = 384) was used as the control group. All control subjects either were blood donors or had been recruited via general practitioner patient registries. In addition, genotyping data were obtained from an additional approximately3,000 healthy UK Caucasian subjects, who were studied as part of the Wellcome Trust Case Control Consortium (WTCCC; for details see the WTCCC Web site at ) (13); these data were used as an additional control. This resource was searched to identify overlap with the SNPs that had been genotyped or to find perfect proxys (r2 = 1) with the SNPs.
###end p 17
###begin title 18
Genotyping
###end title 18
###begin p 19
###xml 359 363 357 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRF1</italic>
###xml 373 377 371 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GZMB</italic>
###xml 387 393 385 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UNC13D</italic>
###xml 407 413 405 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rab27a</italic>
###xml 460 464 458 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRF1</italic>
###xml 488 490 486 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
Haplotype-tagging SNPs were selected from the HapMap database (on the HapMap Web site at www.hapmap.org), and additional informative SNPs were selected from the National Center for Biotechnology Information (NCBI) SNP database (on the NCBI Web site at www.ncbi.nlm.nih.gov/SNP). SNPs with a minor allele frequency (MAF) of >/=10% were selected; these were in PRF1 (n = 3), GZMB (n = 5), UNC13D (n = 7), and Rab27a (n = 11). In addition, the A91V change in the PRF1 gene was also studied (14). Genotyping was performed using MassArray high-throughput DNA analysis with matrix-assisted laser desorption ionization-time-of-flight mass spectrometry (Sequenom, San Diego, CA). Amplifications were conducted according to the manufacturer's protocol. Polymerase chain reaction primers and probe sequences are available from the corresponding author upon request.
###end p 19
###begin title 20
Statistical analysis
###end title 20
###begin p 21
###xml 434 435 430 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 736 744 <span type="species:ncbi:9606">patients</span>
The raw data were "cleaned" prior to analysis, which allowed us to remove DNA samples that failed to genotype for >/=20% of the SNPs assayed, and also to remove the SNPs that failed detection in >/=20% of samples. Hardy-Weinberg equilibrium was determined using Stata version 8 software (College Station, TX) in the case and control groups separately. SNPs were removed from the analysis if deviation from Hardy-Weinberg equilibrium (P </= 0.05) was observed in the controls. Genotype counts in the control panel from the WTCCC (n = 2,938) were compared with those in our own control group. In the case of nonsignificant differences between the control groups, data were combined, and the total control population was compared with the patients with systemic-onset JIA.
###end p 21
###begin p 22
###xml 124 125 124 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
For single-point analysis, associations were investigated by chi-square test or Fisher's exact test, using Stata version 8. P values less than or equal to 0.05 were considered significant. For multipoint analysis, linkage disequilibrium was calculated, and associations of varying-length haplotypes were tested using the expectation-maximization algorithm. This was implemented using HelixTree software ().
###end p 22
###begin p 23
###xml 148 152 146 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRF1</italic>
###xml 407 414 403 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl3">Table 3</xref>
This study had 80% power to detect an odds ratio of >/=2.0, at the 5% significance level, for all of the SNPs studied except for the A91V change in PRF1, for which the study had 80% power to detect an odds ratio of >/=2.4, also at the 5% significance level. These levels were determined using Quanto software (). Utilization of the WTCCC control genotype data enhanced the study power for certain SNPs (see Table 3), providing 82% power to detect an odds ratio of >/=1.8, again at the 5% significance level.
###end p 23
###begin title 24
RESULTS
###end title 24
###begin p 25
###xml 24 28 24 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRF1</italic>
###xml 46 50 46 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GZMB</italic>
###xml 72 78 72 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rab27a</italic>
###xml 218 222 218 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRF1</italic>
###xml 279 280 277 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 433 437 429 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GZMB</italic>
###xml 447 453 443 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UNC13D</italic>
###xml 467 473 463 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rab27a</italic>
Three SNPs, rs88581 (in PRF1), rs10873219 (in GZMB), and rs11630859 (in Rab27a), deviated from Hardy-Weinberg equilibrium in the controls, and were therefore excluded from any further analysis. Our genotyping data for PRF1 captured 80% of the common SNPs (MAF >/=0.05), with an r2 value >/= 0.8, that are present in the phase II CEPH HapMap resource (listed at www.hapmap.org). Similarly, the coverage was 88% of the common SNPs for GZMB, 86% for UNC13D, and 97% for Rab27a.
###end p 25
###begin p 26
###xml 163 164 163 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 210 218 208 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Tables 1</xref>
###xml 223 224 221 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">2</xref>
###xml 55 63 <span type="species:ncbi:9606">patients</span>
The SNP genotype frequencies were compared between the patients with systemic-onset JIA and our control panel of healthy individuals. No significant associations (P </= 0.05) were observed for any of the SNPs (Tables 1 and 2). Furthermore, no significant associations of haplotypes were seen for any of the loci studied
###end p 26
###begin p 27
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRF1</italic>
###xml 9 13 9 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GZMB</italic>
###xml 75 83 <span type="species:ncbi:9606">patients</span>
PRF1 and GZMB single-nucleotide polymorphism (SNP) genotype frequencies in patients with systemic-onset juvenile idiopathic arthritis (JIA) and controls
###end p 27
###begin p 28
By chi-square test.
###end p 28
###begin p 29
By Fisher's exact test.
###end p 29
###begin p 30
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">UNC13D</italic>
###xml 11 17 11 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rab27a</italic>
###xml 79 87 <span type="species:ncbi:9606">patients</span>
UNC13D and Rab27a single-nucleotide polymorphism (SNP) genotype frequencies in patients with systemic-onset juvenile idiopathic arthritis (JIA) and controls
###end p 30
###begin p 31
By chi-square test.
###end p 31
###begin p 32
By Fisher's exact test.
###end p 32
###begin p 33
###xml 737 744 737 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl3">Table 3</xref>
For 7 of the SNPs included in this study, genotyping information from an additional 2,938 control subjects was available from the WTCCC (). No individual within our own control panel had been studied as part of the WTCCC. None of the SNPs in this additional control group deviated from Hardy-Weinberg equilibrium. There were no statistically significant differences in the genotype frequencies between our control panel and this large set of control data for the 7 SNPs of interest. Therefore, the control groups were combined for comparison of their genotype frequencies with those found in the systemic-onset JIA group. Despite the increased number of controls, no SNP was found to be significantly associated with systemic-onset JIA (Table 3)
###end p 33
###begin p 34
###xml 0 19 0 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRF1, GZMB, UNC13D,</italic>
###xml 24 30 24 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rab27a</italic>
###xml 159 160 159 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="tf3-1">*</xref>
###xml 73 81 <span type="species:ncbi:9606">patients</span>
PRF1, GZMB, UNC13D, and Rab27a single-nucleotide polymorphisms (SNPs) in patients with systemic-onset juvenile idiopathic arthritis (JIA) and combined controls*
###end p 34
###begin p 35
Values are the no. (%) of subjects. 1 = wild-type allele; WTCCC = Wellcome Trust Case Control Consortium.
###end p 35
###begin title 36
DISCUSSION
###end title 36
###begin p 37
Host survival depends on an immune system that can protect against infectious pathogens and provide control mechanisms that spare the host from immune damage. The condition known as MAS comprises a set of symptoms caused by the excessive activation and proliferation of T cells and well-differentiated macrophages. This activation is known to accompany the presentation of systemic-onset JIA. In many such cases, an overwhelming inflammatory reaction occurs, which can be fatal. Clinically, MAS resembles secondary HLH.
###end p 37
###begin p 38
###xml 75 76 75 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 253 261 <span type="species:ncbi:9606">patients</span>
###xml 324 331 <span type="species:ncbi:9606">patient</span>
###xml 530 538 <span type="species:ncbi:9606">patients</span>
###xml 685 693 <span type="species:ncbi:9606">patients</span>
Genes contributing to the pathogenesis of HLH are beginning to be defined (9). We aimed to determine whether any SNP within these key genes conferred an increased risk of susceptibility to systemic-onset JIA. We did not attempt to study a population of patients with systemic-onset JIA having a known history of MAS. Such a patient population would be useful to examine genetically. However, collection of such a cohort would require collaboration with multiple centers worldwide, and there is the possibility that the numbers of patients involved would still be small and of limited informative value for genetic association studies. Furthermore, we do not know which, if any, of the patients with systemic-onset JIA included in the present study experienced MAS. Instead, we attempted to determine whether there is a shared genetic basis between MAS/HLH and systemic-onset JIA per se, recognizing that other genes and as yet unidentified environmental triggers are also required for the expression of the systemic-onset JIA phenotype.
###end p 38
###begin p 39
###xml 525 527 525 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
No association was seen for any of the SNPs in each of the 4 genes considered. This remained the case despite our attempt to increase the study power by accessing additional control genotype data. We can therefore conclude that these SNPs do not contribute a substantial risk of susceptibility to systemic-onset JIA. Increasingly, it is becoming apparent that for complex conditions such as systemic-onset JIA, the proportional risk at any one locus is small, with odds ratios substantially lower than 1.8 becoming the norm (15). In this respect, our study remains underpowered. However, it does represent one of the largest systemic-onset JIA cohorts available for genetic investigation, and our study hypothesis was based on observations of both clinical and functional outcomes.
###end p 39
###begin p 40
###xml 66 83 66 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRF1, GZMB, UN13D</italic>
###xml 88 94 88 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rab27a</italic>
###xml 196 204 <span type="species:ncbi:9606">patients</span>
In conclusion, we could not detect an association between SNPs in PRF1, GZMB, UN13D, or Rab27a and an increased risk of susceptibility to systemic-onset JIA. Further studies, in larger cohorts of patients with systemic-onset JIA, are required to evaluate whether these genes contribute a more subtle risk of disease susceptibility than could be determined from this study.
###end p 40
###begin title 41
AUTHOR CONTRIBUTIONS
###end title 41
###begin p 42
Dr. Donn had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
###end p 42
###begin p 43
###xml 0 13 0 13 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Study design.</bold>
Study design. Donn, Baildam, Ramanan.
###end p 43
###begin p 44
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Acquisition of data.</bold>
Acquisition of data. Ellison, Day, Baildam, Ramanan.
###end p 44
###begin p 45
###xml 0 36 0 36 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Analysis and interpretation of data.</bold>
Analysis and interpretation of data. Donn, Lamb, Day, Ramanan.
###end p 45
###begin p 46
###xml 0 23 0 23 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Manuscript preparation.</bold>
Manuscript preparation. Donn, Ramanan.
###end p 46
###begin p 47
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Statistical analysis.</bold>
Statistical analysis. Donn, Lamb.
###end p 47
###begin p 48
We thank the British Society of Paediatric and Adolescent Rheumatology study group members: Dr. M. Abinun, Dr. M. Becker, Dr. A. Bell, Professor A. Craft, Dr. E. Crawley, Dr. J. David, Dr. H. Foster, Dr. J. Gardener-Medwin, Dr. J. Griffin, Dr. A. Hall, Dr. M. Hall, Dr. A. Herrick, Dr. P. Hollingworth, Dr. L. Holt, Dr. S. Jones, Dr. G. Pountain, Dr. C. Ryder, Professor T. Southwood, Dr. I. Stewart, Dr. H. Venning, Dr. L. Wedderburn, Professor P. Woo, and Dr. S. Wyatt.
###end p 48
###begin title 49
REFERENCES
###end title 49
###begin article-title 50
Systemic onset juvenile rheumatoid arthritis
###end article-title 50
###begin article-title 51
Juvenile rheumatoid arthritis: outcome and treatment for the 1990s
###end article-title 51
###begin article-title 52
Does systemic-onset juvenile idiopathic arthritis belong under juvenile idiopathic arthritis?
###end article-title 52
###begin article-title 53
Natural killer cell dysfunction: a common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis?
###end article-title 53
###begin article-title 54
Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders
###end article-title 54
###begin article-title 55
###xml 82 90 <span type="species:ncbi:9606">patients</span>
Reactive haemophagocytic syndrome in adult-onset Still's disease: a report of six patients and a review of the literature
###end article-title 55
###begin article-title 56
###xml 41 49 <span type="species:ncbi:9606">patients</span>
Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis
###end article-title 56
###begin article-title 57
Is macrophage activation syndrome a new entity?
###end article-title 57
###begin article-title 58
Hemophagocytic lymphohistiocytosis and related disorders
###end article-title 58
###begin article-title 59
###xml 35 43 <span type="species:ncbi:9606">patients</span>
Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome
###end article-title 59
###begin article-title 60
Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome
###end article-title 60
###begin article-title 61
International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001
###end article-title 61
###begin article-title 62
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
###end article-title 62
###begin article-title 63
Perforin activity and immune homeostasis: the common A91V polymorphism in perforin results in both presynaptic and postsynaptic defects in function
###end article-title 63
###begin article-title 64
Implications of small effect sizes of individual genetic variants on the design and interpretation of genetic association studies of complex diseases
###end article-title 64

